BackRaising the bar in chronic kidney disease management
8 September 2023
- Click on the timestamp to jump to the topic you are interested in.
- 00:00:05 Opening remarks by Dr Anita Sharma 00:04:09 Session 1. The role of PCPs in the early screening, diagnosis, and treatment of CKD by Dr Anita Sharma 00:24:05 Session 2. Cardio renal benefits of empagliflozin in EMPA-KIDNEY: The final piece of the puzzle by Prof David Cherney 00:56:28 Session 3. Case study: Early stage CKD patient with a higher eGFR by Dr Anita Sharma and Prof David Cherney 01:28:24 5 key takeaways and closing by Dr Anita Sharma
Date: August 2023. RIN No: SC-MY-02448
×
Dr Anita Sharma
University of Queensland, Australia
- Practice Principal at Platinum Medical Centre, and Senior Lecturer, Primary Care Unit, University of Queensland
- Member of Education Committee, Royal College of General Practitioners (RACGP), co-author of the RACGP General Practice Management of type 2 diabetes handbook
- Special interest in Aviation Medicine and is a Designated Aviation Medical Examiner and a Medical Review Officer for Civil Aviation Authority of Australia
- Professional interests include education of GPs registrars, medical students and fellow GPs and development of education modules in type 2 diabetes, CKD, heart failure, atrial fibrillation, diabetes, osteoporosis, obesity, anaemia, and medico-legal matters
×
Prof David Cherney
University of Toronto, Canada
- Professor of Medicine: Division of Nephrology University of Toronto Ontario Canada
- Senior Scientist, Nephrology, University Health Network, Faculty of Medicine, Toronto General Hospital Research Institute, Ontario, Canada
- Director Renal Physiology Laboratory, a clinician scientist, and a physician in the Division of Nephrology at the Toronto General Hospital
- Member Canadian Society of Nephrology, American Society of Nephrology, Canadian Medical, Ontario Medical Association and Royal College of Physicians and Surgeons Canada
- The American Society of Nephrology Distinguished Researcher Award June 2019
- Research interest focuses on the relationship of T1D and renal hemodynamic function, the renin angiotensin aldosterone system, uric acid, urinary biomarkers and glucose lowering therapies